Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.17 | N/A |
| PEG Ratio (TTM) | -0.89 | N/A |
| P/S Ratio (TTM) | 0.98 | N/A |
| P/B Ratio (TTM) | 1.96 | N/A |
| P/FCF Ratio (TTM) | 40.75 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.14 | N/A |
| Price to 5YR AVG FCF Ratio | 12.00 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.20% | N/A |
| ROE (TTM) | 19.41% | N/A |
| Net Profit Margin (TTM) | 9.80% | N/A |
| ROIC 5YR AVG | 36.02% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.77% | 147.52% | 89.37% |
| Revenue | -1.11% | 24.00% | 15.47% |
| Net Income | -10.33% | 139.64% | 80.51% |
| Cash Flow | 6.26% | 30.88% | 34.79% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.39 | N/A |
| Quick Ratio (TTM) | 1.26 | N/A |
| D/E Ratio (TTM) | 0.41 | N/A |
| Interest Coverage (TTM) | 39.32 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 4.84 | N/A |
| LTL to 5YR AVG FCF | 1.85 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.52% | N/A |